Skip to main content

Prevention of Deleterious Effects of Reperfusion Injury Using One-Week High-Dose Allopurinol

Digestive Diseases and Sciences volume 46, pages 430–437 (2001)Cite this article

Abstract

Allopurinol has been widely used to reduce the severity of the reperfusion injury. However, conflicting data have been reported regarding the dosage, the duration of the timing, and the administrative regimen of the drug. The aim of this study was, therefore, to evaluate the effects of short versus long periods of allopurinol pretreatment on the anastomotic healing of intestines, directly after being subjected to ischemia–reperfusion (IR) stress. Furthermore, the effects of an allopurinol pretreatment on the survival rate following IR stress, was also assessed. One hundred thirty-seven male Wistar rats with a median weight of 235 (range, 180–275) g used in the study. In group I (control group, N = 20) superior mesenteric artery (SMA) and collateral vessels were isolated but not occluded. In group II, the profound IR group (PIR, N = 42), the SMA was occluded immediately distal to the aorta with collateral interruption using an atraumatic arterial clip for 30 min. In group III [two days of allopurinol (ALL) pretreatment group, 2ALL, N = 38], allopurinol (100 mg/kg body wt) was given intraperitoneally on a daily basis for two days prior to the experiment. In group IV (seven days of allopurinol pretreatment group, 7ALL, N = 37), the same pretreatment and the allopurinol schedule was performed for seven days before surgery. All animals underwent 3 cm of ileal resection and primary anastomosis, 10 cm proximal to ileocecal valve. Within each group, animals were anesthetized either on the third or seventh postoperative days. Abdominal wound healing, intraabdominal adhesions, anastomotic complications, anastomotic bursting pressure measurements, and bursting site were recorded as were the histopathologic evaluation. No rats in group I, 20 rats in group II, 18 rats in group III, and 7 rats in group IV died (P = 0.0003). Anastomotic dehiscence was found in one of 20 group I, in 11 of 22 in group II, in 9 of 20 in group III, and in 3 of 30 in group IV (P = 0.0003). On the third and seventh days, the median bursting pressures of the anastomosis were determined: 42 and 235 mm Hg in group I, 17 and 105 mm in Hg in group II, 22 and 183 mm Hg in group III, and 36 and 214 mm Hg in group IV (P < 0.0001). The burst occurred at the anastomoses in all animals tested on the third postoperative day, one in group I, six in group II, four in group III and one in group IV on the seventh postoperative day (P < 0.01). All deleterious effects of reperfusion injury on intestinal anastomosis healing, including survival rates and the histopathological parameters, were significantly prevented by seven days, but not two days, of high-dose allopurinol pretreatment.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

REFRENCES

  1. Schoenberg MH, Beger HG: Reperfusion injury after intestinal ischemia. Crit Care Med 21:1376–1387, 1993

    Google Scholar 

  2. Grace PA: Ischemia-reperfusion injury. Br J Surg 81: 631–647, 1994

    Google Scholar 

  3. Zimmerman BJ, Granger DN: Oxygen free radicals and the gastrointestinal tract: Role in ischemia reperfusion injury. Hepato-Gastroenterol 41:337–342, 1994

    Google Scholar 

  4. Schiller HJ, Reilly PM, Bulkley GB: Antioxidant therapy. Crit Care Med 20:92–102, 1993

    Google Scholar 

  5. Lucchesi BR: Complement, neutrophils and free radicals: Mediators of reperfusion injury. Drug Res 44:420–431, 1994

    Google Scholar 

  6. Köksoy C, Kuzu MA, Kesenci M, Uydeş-Doğan BS, Aydemir-Koksoy A, Demirpence E: Effects of intestinal ischemia reperfusion injury on major conduit arteries. J Invest Surg 13:35–43, 2000

    Google Scholar 

  7. Köksoy C, Kuzu MA, Ergŭn H, Demirpence E, Zülfikaroğlu B. Intestinal ischemia-reperfusion impairs vasomotor functions of pulmonary vascular bed. Ann Surg 231:105–111, 2000

    Google Scholar 

  8. Qian T, Nieminen AL, Herman B, Lemasters JJ: Mitochondrial permeability transition in pH-dependent reperfusion injury to rat hepatocytes. Am J Physiol 273:c1783–c1792, 1997

    Google Scholar 

  9. MacLellan WR, Schneider MD: Death by Design. Programmed cell death in cardiovascular biology and disease. Circ Res 81:137–144, 1997

    Google Scholar 

  10. Austen WG, Kyriakides C, Favuzza J, Wang Y, Kobzik L, Moore FD, Hechtman HB: Intestinal ischemia-reperfusion injury is mediated by the membrane attack complex. Surgery 126:343–348, 1999

    Google Scholar 

  11. Megison SM, Horton JW, Chao H, Walker PB: High dose versus low dose enteral allopurinol for prophylaxis in mesenteric ischemia. Circ Shock 30:323–329, 1990

    Google Scholar 

  12. Megison SM, Horton JW, Chao H, Walker PB: Prolonged survival and decreased mucosal injury after low dose enteral allopurinol prophylaxis in mesenteric ischemia. J Pediatr Surg 25:917–921, 1990

    Google Scholar 

  13. Garcia JG, Rollan CM, Enrinquez R, Madruga MH, Hermandez EM, Nunez JFM, Alonso AG: Improved survival in intestinal ischemia by allopurinol not related to xanthine-oxidase inhibition. J Surg Res 48:144–146, 1990

    Google Scholar 

  14. Vaughan GW, Horton JW, Walker PB: Allopurinol prevents intestinal permeability changes after ischemia-reperfusion injury. J Pediatr Surg 27:968–973, 1992

    Google Scholar 

  15. Karwinshi W, Fastad M, Ulvik R, Soreide O: Sixty-minute normothermic liver ischemia in rats. Transplantation 52: 231–234, 1991

    Google Scholar 

  16. Boros M, Bako L, Nagy S: Effect of antioxidant therapy on cyclooxygenase-derived eicosanoid release during intestinal ischemia-reperfusion. Eur Surg Res 23:141–150, 1991

    Google Scholar 

  17. Picard Ami LA Jr, MacKay ABA, Kerrigan CL: Effects of allopurinol on survival of experimental pig flaps. Plast Reconstr Surg 89:1098–1104, 1992

    Google Scholar 

  18. Angel MF, Ramasastry SS, Swartz WM, Narayanan K, Basford RE, Futrell JW: Augmentation of skin flap survival with allopurinol. Ann Plast Surg 18:494–498, 1987

    Google Scholar 

  19. Im MJ, Shen WH, Pak CJ: Effect of allopurinol on survival of hyperemic island skin flaps. Plast Reconstr Surg 73:276–278, 1984

    Google Scholar 

  20. Leung FW, Su KC, Passaro E, Guth PH: Regional differences in gut blood flow and mucosal damage in response to ischemia and reperfusion. Am J Physiol 263:G301–G335, 1992

    Google Scholar 

  21. Qayumi KA, Janusz MT, Dorovoni-Zis K, Lyster DM, Jamieson EWR, Poostizadeh A, Feeley EJE, Sangari-Nikbakth M: Additive effect of allopurinol and injury caused by aortic cross clamping. J Thorac Cardiovac Surg 107:1203–1209, 1994

    Google Scholar 

  22. Svensson LG, Von Ritter CM, Groeneveld HT, Rickards ES, Hunter SJ, Robinson MF, Hinder RA: Cross-clamping of the thoracic aorta: Influence of aortic shunts, laminectomy, papaverine, calcium channel blocker, allopurinol and superoxide dismutase on spinal cord blood flow and apraplegia in boboon Ann Surg 204:38–47, 1986

    Google Scholar 

  23. Qayumi AK, Jamieson WRE, Godin DV, Lam S, Ko KM, Germann E, Van der Broek J: Response to allopurinol pretreatment in a swine model of heart-lung transplantation. J Invest Surg 3:331–340, 1990

    Google Scholar 

  24. Argibay P, Mazza O, Bonadeo G, Cristiansen S, Hyon S: Administration of oral allopurinol as a means of preventing ischemia and reperfusion damage to the intestine. Transplant Proc 28:2640–2641, 1996

    Google Scholar 

  25. Kuzu MA, Köksoy C, Kale IT, Tanik A, Terzi C, Elhan A: Reperfusion injury delays healing of intestinal anostomosis in a rat. Am J Surg 176:348–351, 1998

    Google Scholar 

  26. Kuzu MA, Tanik A, Kale IT, Aşlar AK, Köksoy C, Terzi C: Ischemia reperfusion as a systemic phenomenon impairs the anastomotic healing in left colon. World J Surg 24:990–994, 2000

    Google Scholar 

  27. Arisawa S, Arisawa T, Ohashi M, Nitta Y, Ikeya T, Asai J: Effect of the hydroxyl radical on fibroblast mediated collagen remodeling in vitro. Clin Exp Pharmacol Physiol 23:222–228, 1996

    Google Scholar 

  28. Knightly JJ, Agostino D, Cliffton EE: The effect of fibrinolysin and heparin on the formation of peritoneal adhesions. Surgery 52:250–258, 1962

    Google Scholar 

  29. De Roy van Zuidewijn DBW, Schillings PHM, Wobbes T, de Boer HHM: Histological evaluation of wound healing in experimental intestinal anastomoses: Effects of antineoplastic agents. Int J Exp Pathol 73:465–484, 1992

    Google Scholar 

  30. Levine JS, Jacobson ED: Intestinal ischemic disorders. Dig Dis 13:3–24, 1995

    Google Scholar 

  31. Takeyoshi I, Iwanami K, Ohwada S, Kawashima Y, Kawati K, Aiba M, Kobayashi J, Koyoma T, Matsumoto K, Satoh S, Morishita Y. Effect of FRI67653 on small bowel ischemiareperfusion injury on dogs. Dig Dis Sci 44:2334–2343, 1999

    Google Scholar 

  32. Miner IJ, Motamen-Tavaf H, Stojadinovic A and Donohwe-Shea T: Ischemia-reperfusion protects the rat small intestine against subsequent injury. J Surg Res 82:1–10, 1999

    Google Scholar 

  33. Megison SM, Horton JW, Chao H, Walker PB: A new model for intestinal ischemia in the rat. J Surg Res 49:168–174, 1990

    Google Scholar 

  34. Rothenbach P, Turnage RH, Iglesias J, Riva A, Bartula L, Myers S: Downstream effects of splanchnic ischemiareperfusion injury on renal function and eicosanoid release. J Appl Physiol 83:530–536, 1997

    Google Scholar 

  35. Das DK, Engelman RM, Clement R, Otani H, Prasad MR, Rao PS: Role of xanthine oxidase inhibitor as free radical scavenger: A novel mechanism of action of allopurinol and oxypurinol in myocardial salvage. Biochem Biophys Res Commun 148:314–319, 1987

    Google Scholar 

  36. Moorhouse PC, Grotveld M, Halliwell B, Quinlan JG, Gutteridge JM: Allopurinol and oxypurinol are hydroxyl radical scavengers. FEBS Lett 213:23–28, 1987

    Google Scholar 

  37. Cameron JS, Simmonds HA, Hatfield PJ, Jones AS, Caderhead A: The big as an animal model for purine metabolic studies. In Purine Metabolism in Man. P Sperling, A de Vries, JB Wyngaarden (eds). New York, Plenum Press, 1974, p 691

    Google Scholar 

Download references

Author information

Affiliations

  1. Departments of Surgery, University of Dokuz Eylül, Izmir

    Cem Terzi, M. Ayhan Kuzu, A. Keşşaf Aşlar, İ. Taner Kale, Adil Tanik & C. Köksoy

  2. Ankara Numune Hospital, University of Ankara, Ankara, Ankara, Turkey

    Cem Terzi, M. Ayhan Kuzu, A. Keşşaf Aşlar, İ. Taner Kale, Adil Tanik & C. Köksoy

Authors
  1. Cem Terzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Ayhan Kuzu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Keşşaf Aşlar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. İ. Taner Kale
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Adil Tanik
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. C. Köksoy
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Terzi, C., Kuzu, M.A., Aşlar, A.K. et al. Prevention of Deleterious Effects of Reperfusion Injury Using One-Week High-Dose Allopurinol. Dig Dis Sci 46, 430–437 (2001). https://doi.org/10.1023/A:1005625504535

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1005625504535

  • ischemia
  • reperfusion
  • allopurinol
  • intestinal anastomosis